A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring

Name: A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring
Author: Voss, Martin H

A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring — المؤلف: Voss, Martin H — Clinical cancer research : an official journal of the American Association for Cancer Research 20200619

المؤلف: Voss, Martin H
النشر: Clinical cancer research : an official journal of the American Association for Cancer Research 20200619
الوصف: 2699-2707 p.
الموضوعات: Adult؛ Aged؛ Benzimidazoles؛ Drug Administration Schedule؛ Female؛ Follow-Up Studies؛ Gene Fusion؛ Humans